Bill journey · stage 2 of 5
Under committee review
What it doesSummary reported to house with amendment(s) (Jun 12, 2018)
Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act
This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions. Drug use review programs must also identify prescribing or billing practices by providers that indicate abuse or excessive utilization.
What just happenedJun 12, 2018
Placed on the Union Calendar, Calendar No. 563.
Who’s behind it
Placed on the Union Calendar, Calendar No. 563.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-728.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-728.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act
This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions. Drug use review programs must also identify prescribing or billing practices by providers that indicate abuse or excessive utilization.
Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act
This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions.